Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Titel:
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Auteur:
Moriarty, Patrick M. Jacobson, Terry A. Bruckert, Eric Thompson, Paul D. Guyton, John R. Baccara-Dinet, Marie T. Gipe, Daniel